Gastrointestinal Disorders · Nov 16, 2026

Potential Role of New Dietary Regimes in the Management of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

By Forlano R, Mullish BH, Iorra FQ et al.

Dietary modification remains a cornerstone in the management of metabolic dysfunction-associated steatotic liver disease (MASLD), alongside a program of physical activity and sustained weight loss. International guidelines recommend the Mediterranean diet in MASLD patients, while other new dietary regimes have become more popular in clinics. In this narrative review, we review the evidence supporting the use of vegetarian diets, ketogenic diets, and time-restricted eating in patients with MASLD. Moreover, we highlight the evidence on the effects of each diet on hepatic and cardiometabolic outcomes, safety, and long-term sustainability. Overall, several regimes have demonstrated a reduction in hepatic steatosis, while the evidence supporting fibrosis regression is lacking. Specifically, small sample sizes, heterogeneous interventions, short follow-up, and limited histological assessment represent the main limitations of the studies. Finally, macro- and micro-nutrient deficiency, hypoglycemia and sarcopenia risk, and safety in advanced liver disease represents important disadvantages for applying these diets in patients with MASLD. There is need for longer-term randomized trials incorporating histological or validated non-invasive endpoints in order to establish their comparative efficacy, safety, and durability in MASLD.

doi.org/10.3390/gidisord8040078Open accessInterventions

AgingResearch.News